...
机译:Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44
Department of Medicine, University of California, San Diego Moores Cancer Center, San Diego, CA 92093, United States;
Department of Discovery Oncology, Pharma Research, and Early Development, Roche Diagnostics GmbH, 82377 Penzberg, Germany;
Animal model; Antibody therapy; Cell survival; Preclinical studies;